Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.8.0.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2018
Schedule of stock-based compensation expense

Included in the accompanying condensed consolidated statements of operations are the following amounts of stock-based compensation for the three months ended March 31, 2018 and 2017 (amounts in thousands):

 

 

 

 

 

 

 

 

 

Three months

 

 

 

ended

 

 

 

March 31,

 

 

 

2018

 

2017

 

Operating expense

    

$

 —

    

 1

 

Selling, general and administrative

 

 

1,388

 

1,220

 

Research and development

 

 

17

 

227

 

 

 

$

1,405

 

1,448

 

 

Series A common stock  
Schedule of stock awards activity

 

 

 

 

 

 

 

 

 

 

 

 

    

    

    

    

 

    

Weighted

    

    

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

remaining

 

Aggregate

 

 

 

 

 

 

 

contractual

 

intrinsic

 

 

Series A

 

WAEP

 

life

 

value

 

 

(in thousands)

 

 

 

 

(in years)

 

(in millions)

Outstanding at January 1, 2018

 

404

 

$

33.16

 

 

 

 

 

Granted

 

 —

 

$

 —

 

 

 

 

 

Exercised

 

(5)

 

$

27.88

 

 

 

 

 

Forfeited/cancelled

 

 —

 

$

 —

 

 

 

 

 

Outstanding at March 31, 2018

 

399

 

$

33.24

 

1.7

 

$

21

Exercisable at March 31, 2018

 

397

 

$

33.19

 

1.7

 

$

20

 

Series C common stock  
Schedule of stock awards activity

 

 

 

 

 

 

 

 

 

 

 

 

    

    

    

    

 

    

Weighted

    

    

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

remaining

 

Aggregate

 

 

 

 

 

 

 

contractual

 

intrinsic

 

 

Series C

 

WAEP

 

life

 

value

 

 

(in thousands)

 

 

 

 

(in years)

 

(in millions)

Outstanding at January 1, 2018

 

2,388

 

$

43.35

 

 

 

 

 

Granted

 

 —

 

$

 —

 

 

 

 

 

Exercised

 

(24)

 

$

28.57

 

 

 

 

 

Forfeited/cancelled

 

 —

 

$

 —

 

 

 

 

 

Outstanding at March 31, 2018

 

2,364

 

$

43.50

 

5.0

 

$

100

Exercisable at March 31, 2018

 

844

 

$

34.54

 

1.9

 

$

43